Why the study?
Is a specific two-stage prothrombin assay as useful as standard methods for monitoring oral anticoagulant treatment?
Is a specific two-stage prothrombin assay as useful as standard methods for monitoring oral anticoagulant treatment?
A specific two-stage prothrombin assay is a useful indicator of the effect of oral anticoagulant treatment, comparable to generally used methods like Thrombotest.
Answers are grounded in this paper and cite their sources.
May support two-stage prothrombin assay as comparable monitor; leaves open outcome validation before changing practice.
A specific two‐stage prothrombin assay has been applied for the control of oral anticoagulant treatment in comparison with a one‐stage prothrombin assay and an immunological assay of reactive prothrombin, as well as with Thrombotest and the prothrombin‐proconvertin (P‐P) method and with specific assays of factors IX and X. All the methods used were fairly well correlated but showed different activity levels. Prothrombin values of 20–45% corresponded to P‐P values of 10–25% and Thrombotest values of 5–20%. Values of the present two‐stage prothrombin assay were in accordance with prothrombin values immunologically determined. A large number of patients on long‐term anticoagulant treatment were routinely controlled with Thrombotest, patients with complications with the present prothrombin method as well. Minor bleeding complications occurred in patients with values within the therapeutic range of both methods and to the same extent. The activity of the inhibitor induced by the treatment was about the same in patients with bleeding complications as in the other patients. It does not seem necessary for the treatment to register this activity. The specific prothrombin assay seems to be as useful an indicator of the effect of anticoagulant treatment as the methods generally used.
No takes yet. Share an insight, caveat, or question.
Norén et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: